CizzaG, BrownRJ, RotherKI. Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest, 2012; 35: 541–46.
2.
AmielSA, SherwinRS, SimonsonDC, LauritanoAA, TamborlaneWV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med, 1986; 315: 215–19.
3.
RauschJR, HoodKK, DelamaterA, Shroff PendleyJ, RohanJM, ReevesG, DolanL, DrotarD. Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes. Diabetes Care, 2012; 35: 1219–24.
4.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329: 977–86.
5.
DavisE, KeatingB, ByrneG, RussellM, JonesT. Hypoglycemia: Incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care, 1997; 20: 22–25.
6.
HollRW, SwiftPG, MortensenHB, LynggaardH, HougaardP, AanstootHJ, ChiarelliF, DanemanD, DanneT, DorchyH, GarandeauP, GreeneS, HoeyHM, KaprioEA, KocovaM, MartulP, MatsuuraN, RobertsonKJ, SchoenleEJ, SovikO, TsouRM, VanelliM, AmanJ. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr, 2003; 162: 22–29.
7.
PihokerC, BadaruA, AndersonA, MorganT, DolanL, DabeleaD, ImperatoreG, LinderB, MarcovinaS, Mayer-DavisE, ReynoldsK, Klingensmith GJ; SEARCH for Diabetes in Youth Study Group. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: The search for diabetes in youth study. Diabetes Care, 2013; 36: 27–33.
8.
BergenstalRM, TamborlaneWV, AhmannA, et al.Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med, 2010; 363: 311–20.
9.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, TamborlaneWV, BeckRW, et al.Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359: 1464–76.
10.
HovorkaR, KumareswaranK, HarrisJ, et al.Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: Crossover randomised controlled studies. Br Med J, 2011; 342: d1855.
11.
MaurasN, BeckR, XingD, et al., Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care, 2012; 35: 204–10.
12.
WeinzimerSA, SteilGM, SwanKL, DziuraJ, KurtzN, TamborlaneWV. Fully automated closed-loop insulin delivery versus semi automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 2008; 31: 934–39.
13.
CobryE, McFannK, MesserL, GageV, VanderWelB, HortonL, ChaseHP. Timing of meal insulin boulses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Tech Ther, 2009; 12: 173–77.
14.
ChaseHP, LutzK, PencekR, ZhangB, PorterL. Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study. J Pediatr, 2009; 155: 369–73.